ABSTRACT. Porcine β-defensin 2 (pBD2) is an antimicrobial peptide in pigs that plays an important role in the immune system by preventing bacterial invasion. To produce an anti-pBD2 antibody, which is not commercially available, we expressed and purified a soluble, his-tagged version of pBD2 (his-pBD2). Purified pBD2 was injected into New Zealand white rabbits to generate polyclonal antiserum. Anti-pBD2 antibodies were purified by ammonium sulfate precipitation, followed by diethylaminoethyl cellulose ionexchange chromatography. The purified polyclonal antibody showed high sensitivity, with a titer as high as 204,800 by enzyme-linked immunosorbent assay, and it also showed high specificity for both his-pBD2 and native pBD2, as assessed by western blotting. Furthermore, immunohistochemistry analysis using the purified antibody revealed that pBD2 protein is distributed in the tongue, liver, kidney, small intestine, and large intestine of pigs. These results indicate that the prepared polyclonal antibody will be a useful tool for further studies of the function and mechanism of pBD2.
INTRODUCTION
Defensins are a large family of cationic antimicrobial peptides that comprise of 30-50 amino acid residues and exist widely in various species of plants and animals (Hancock, 2001; Ganz, 2003; Ganz, 2004; Selsted and Ouellette, 2005; Klüver et al., 2006) . They have broad antimicrobial activity against pathogens, including bacteria, viruses, and fungi (Selsted and Ouellette, 2005; Peschel and Sahl, 2006; Yang et al., 2007; Auvynet and Rosenstein, 2009 ). In addition, they act as signaling molecules in the immune system, function as chemoattractants for memory T cells, immature dendritic cells, and mast cells, and are inflammatory mediators (Yang et al., 1999; Nozdrachev et al., 2006; Choi et al., 2012) .
Mammalian defensins are classified as α, β, and θ defensins based on the connectivity of three disulfide bridges (Lehrer and Ganz, 2002; Selsted and Ouellette, 2005) . Evolutionarily, b-defensins are the oldest of the defensins (Sang et al. 2006) . In pigs, only β-defensins have been found, which were all discovered by genomic sequencing analysis, except for porcine β-defensin 1 (pBD1). Few studies have been conducted on porcine defensins (Shi et al., 1999; Zhang et al., 2000; Sang et al., 2009) . Previous research showed that porcine β-defensin 2 (pBD2) has high antimicrobial activity against Gram-negative and Gram-positive bacteria, including multidrug-resistant bacteria isolated from sick fowl, which makes it a good candidate for antibiotic development (Zhang et al., 2000; Veldhuizen et al., 2008; Li et al., 2013a) . However, the antibacterial mechanism of pBD2 and its role in the immune system, remain unclear. Currently, no antipBD2 polyclonal antibody is commercial available for research. Thus, in this study, we prepared and characterized an anti-pBD2 polyclonal antibody. To generate an anti-pBD2 polyclonal antibody, we used a previously described strain, BL21(DE3)-pET-pBD2 (Gao et al., 2015) , to express a histagged pBD2 (his-pBD2) fusion protein. Polyclonal antibody was prepared by injecting purified hispBD2 into New Zealand white rabbits. The antibody was then characterized using ELISAs, western blots, and immunohistochemistry experiments.
MATERIAL AND METHODS

Expression and purification of his-pBD2
His-pBD2 was expressed by inducing the Escherichia coli strain BL21(DE3)-pET-pBD2, which was constructed in our laboratory, with isopropyl β-D-1-thiogalactopyranoside (IPTG), and the protein was purified as previously described (Li et al., 2013a; Gao et al., 2015) . The purified his-pBD2 was analyzed by SDS-PAGE, and used for the preparation of antibodies.
Preparation and purification of polyclonal antibody against pBD2
Polyclonal antibody was prepared followed previously reported protocols, with some modification (Liu et al., 2009; Liu et al., 2013; Li et al., 2013b) . In brief, purified his-pBD2 protein was mixed with an equal volume of Freund's complete adjuvant (Sigma-Aldrich, St. Louis, MO, USA) at a final concentration of 300 μg/mL. Subsequently, about 100 μg his-pBD2 was injected subcutaneously into the backs of New Zealand white rabbits (3-months old, about 1.5-2 kg). After two weeks, the rabbits were immunized again with 100 μg his-pBD2 in Freund's incomplete adjuvant (Sigma-Aldrich). The third and fourth immunizations were executed with his-pBD2 in Freund's incomplete adjuvant at 2-week intervals. Blood was collected 7 days after the last injection.
The blood was placed at room temperature for 1 h, and then at 4°C overnight, and the supernatants (antisera) were collected via centrifugation at 2,200 g for 10 min. Then, the antisera were mixed with an equal volume of saline solution, and precipitated with 20% saturated ammonium sulfate. After centrifugation at 3,500 rpm for 30 min, the supernatants were collected and precipitated with 50% saturated ammonium sulfate. The final precipitates were dissolved in saline solution, precipitated with 33% saturated ammonium sulfate, and dissolved in saline solution again. The last two steps were repeated three times. Finally the primary, purified antibodies were desalinated by dialysis against PB buffer (10 mM, pH 7.2) until no NH 4 + could be detected. Then, the IgG fraction was further purified by diethylaminoethyl (DEAE)-cellulose chromatography (Parham et al., 1982) ; bound antibodies were eluted using 10 mM PB buffer (10 mM, pH 7.2). The eluted fractions were collected and their absorbance at 280 nm was analyzed. The fractions with the highest absorbance values were pooled, concentrated using polyethylene glycol (PEG) 8000, and identified by SDS-PAGE.
Titer determination by ELISA
The titer of purified anti-pBD2 antibody was determined by indirect ELISA according to previously described protocols, with some modifications (Kroll et al., 2005; Wu et al., 2007; Gao et al., 2012; Xiong et al. 2012; Xin et al., 2013) . First, 96-well plates were coated with 100 μL of the purified hispBD2 antigen, diluted to 20 ng/mL in 0.05 M sodium carbonate coating buffer (pH 9.6), at 4°C overnight, and washed three times with phosphate-buffered saline (PBS)-T buffer (0.05% Tween 20 in PBS, pH 7.4). The plates were then blocked with 300 μL 1% bovine serum albumen (BSA) for 1 h 37°C. After washing three times with PBS-T, the purified anti-pBD2 antibody was used as a primary antibody at different dilutions (from 1:400 to 1:819,200) and incubated at 37°C for 1 h; negative serum at the same dilution was used as a control. Plates were then incubated at 37°C for 1 h with 100 μL of horseradish peroxidase (HRP)-labeled goat anti-rabbit IgG (1:5,000, DingGuo ChangSheng Biotechnology Co., Ltd., Beijing, China) as a secondary antibody. Peroxidase activity was detected at 37°C for 15 min using fresh tetramethylbenzidine (TMB) as a substrate, and the color development was stopped via the addition of 50 μL 2 M H 2 SO 4 . The absorbance at 450 nm was measured using a microplate reader (Stat Fax 2100, Awareness Technologies Inc., Westport, CT, USA). The experiments were repeated three times, and all values are presented as the mean ± standard deviation. The antibody titer was defined as the highest dilution of serum at which the absorbance ratio at 450 nm of the purified antibody and pre-immunization serum was greater than 2:1.
Western blot analysis
To confirm that the antibody could recognize the pBD2 protein in bacteria and in pigs, western blots were performed. Total proteins from the induced BL21(DE3)-pET-pBD2 strain and from strain BL21(DE3) were used as positive and negative controls, respectively. Total protein samples from porcine kidney tissues were used. Western blotting was performed according to a previously reported protocol (Xiong et al., 2012) . Different fractions from different samples were separated by 10% SDS-PAGE, and transferred to a nitrocellulose membrane. The membrane was blocked for 2 h with 5% skimmed milk (Inner Mongolia Yili Industrial Group Co., Ltd., Inner Mongolia, China) in TBS-T buffer (0.05% Tween-20 in TBS, pH 7.5) at room temperature. After three washes with TBST buffer (5 min each), the nitrocellulose membrane was incubated with the purified antipBD2 polyclonal antibody (1:3,000 dilution) at 4°C overnight. Then, the membrane was incubated with HRP-labeled goat anti-rabbit IgG at a dilution of 1:5000 for 2 h at room temperature. Finally, bound secondary antibody was detected using the Super ECL Plus Detection Reagent (Zhongshan biotechnology Co., Ltd., Beijing, China).
Immunohistochemistry analysis
Immunohistochemistry was performed according to a previously reported protocol, with some modifications (Liu et al., 2009) . Tongue, liver, kidney, small intestine (including duodenum and jejunum), and large intestine (rectum) tissues from Large White piglets (about 10 days old) were selected and cut into approximately 1-cm 3 pieces. The samples were suspended and fixed in Bouin's solution for 24 h at room temperature, and then washed and dehydrated in a series of ethanol gradients. Subsequently, samples were embedded in paraffin wax and cut into approximately 5-μm 2 sections. The sections were hydrated by a series of ethanol-to-water gradients and treated with 3% hydrogen peroxide for 10 min, incubated in citrate buffer for 10 min, and incubated with 50 μL anti-goat serum for 30 min at room temperature. Subsequently, the sections were incubated with the purified anti-pBD2 polyclonal antibody at 4°C overnight (1:1000). After washing three times with PBS-T, tissue sections were incubated with HRP-labeled goat anti-rabbit IgG for 60 min at 37°C (1:500) and washed with PBS-T. Finally, the sections were stained with diaminobenzidine (DAB) and counterstained with hematoxylin, dehydrated, and mounted. Brown staining indicates the presence of pBD2. Serum from non-immunized rabbits served as a negative control for the primary antibody.
RESULTS
Purification of his-pBD2
Based on BL21(DE3)-pET-pBD2, which was constructed in our lab, his-pBD2 was expressed and purified as previously described (Li et al., 2013a; Gao et al., 2015) . The molecular weight of purified his-pBD2 was about 12 kDa, and the purity was greater than 90% according to Gel-ProAnalyzer (4.0) analysis (Figure 1) . The results showed that purified his-pBD2 could be used as antigen to immunize New Zealand white rabbits. 
Purification of polyclonal antibody against pBD2
After the rabbits were immunized four times with purified his-pBD2, polyclonal antibody against pBD2 was first precipitated with different concentrations of ammonium sulfate, and further purified by DEAE-cellulose ion-exchange chromatography. The purified antibody showed high purity and consisted of two bands, one was the heavy chain (about 52.5 kDa) and the other was the light chain (about 22.8 kDa), as assessed by SDS-PAGE and analyzed by Gel-Pro Analyzer (4.0), which were close in size to their predicted molecular weights (Figure 2) . 
Titer analysis by ELISA
The titer of the purified anti-pBD2 antibody was measured by ELISA. The polyclonal antibody was diluted by double dilution methods (from 400-to 819,200-fold) and reacted with 100 μL 20 ng/mL his-pBD2. Pre-immunized rabbit serum was used as a negative control. The titer of purified antibody was 204,800, which indicated that the purified polyclonal antibody had good sensitivity for pBD2 (Figure 3) . 
Western blot analysis
The specificity of the purified antibody was analyzed by western blotting. Different samples were separated by 10% SDS-PAGE and transferred to nitrocellulose membranes (Figure 4) . Predicted bands representing pBD2 were found in total protein samples from BL21(DE3)-pET-pBD2 and kidney tissue from pig, while proteins from the BL21(DE3) E. coli strain did not generate any bands. These results indicate that the polyclonal antibody did not react with any E. coli proteins; however, it could recognize pBD2, whether it was the his-tagged fusion protein in E. coli or the native pBD2 without the his-tag in pig, which meant that the polyclonal antibody had good specificity. 
Tissue immunohistochemistry assay
Porcine tongue, liver, kidney, small intestine (including duodenum and jejunum), and large intestine (rectum) were used as samples to test the distribution of pBD2 in pig using the anti-pBD2 antibody. Immunohistochemistry analysis revealed the presence of pBD2 in stratified squamous epithelium in tongue (Figure 5b ), interlobular arteries, and veins between hepatic lobules in the liver (Figure 5d ), inner and outer epithelial cells in renal tubules in the kidney (Figure 5f ), epithelial cells in the intestinal glands and glandular lumen in the small intestine (duodenum and jejunum), and large intestine (rectum) (Figure 5h , j, and l). In contrast, no staining was observed in tissues in the absence of the primary polyclonal antibody (Figure 5a , c, e, g, i, and k). Thus, the polyclonal antibody is able to recognize endogenous pBD2 in tissues and may be used as a useful tool to study the function and mechanism of pBD2. This is the first time that pBD2 has been identified in porcine tissues at the protein level. Immunohistochemical staining in some porcine tissues. Images a, c, e, g, i, and k show tongue, liver, kidney, duodenum, jejunum, and rectum tissue, respectively, which were incubated with serum from non-immunized rabbits as the primary antibody, followed by HRP-labeled goat anti-rabbit IgG. Images b, d, f, h, j. and l show tongue, liver, kidney, duodenum, jejunum, and rectum tissue, respectively, which were incubated with purified anti-pBD2 polyclonal antibody, followed by HRP-labeled goat anti-rabbit IgG. All tissue samples were stained with diaminobenzidine (DAB) and counterstained with hematoxylin. Brown staining indicates the presence of pBD2.
DISCUSSION
Infectious diseases are responsible for significant economic loss in the porcine industry, and multidrug-resistant bacteria are a serious global problem, which affect the morbidity and mortality of infected pigs. Therefore, it is important to find new antimicrobial treatments for use in these diseases. Studies showed pBD2 to have high antimicrobial activity against bacteria, including multidrug-resistant bacteria isolated from sick fowl (Veldhuizen et al., 2008; Li et al., 2013a) , which makes it good candidate for antibiotic development. Furthermore, pBD2 showed low hemolytic activity, high salt-tolerance, and strong thermal stability, which are important properties for its practical application (Li et al., 2013a) . However, the anti-bacterial mechanism of pBD2 and its role in the immune system are unclear. In addition, pBD2 antibodies are not commercially available. Thus, in this study, we prepared and characterized an anti-pBD2 polyclonal antibody.
Based on the BL21(DE3)-pET-pBD2 strain, which was constructed in our lab, his-pBD2 was expressed, purified, and used to immunize rabbits to prepare polyclonal antibody. The polyclonal antibody was precipitated with different concentrations of ammonium sulfate, and further purified by DEAE cellulose chromatography. The purified antibodies showed high sensitivity, with a titer as high as 204,800 by ELISA, and they specially recognized pBD2, whether it was the his-tagged fusion protein in E. coli or the native protein in pigs, as assessed by western blotting. Furthermore, the antibody specifically reacted with pBD2 in different pig tissues, and immunohistochemistry analyses revealed the distribution of pBD2 in the tongue, liver, kidney, small intestine (duodenum and jejunum), and large intestine (rectum) of Large White pigs. The results revealed a more detailed distribution of pBD2 at the protein level compared with that reported at the RNA level (Chen et al., 2010) . Therefore, the prepared polyclonal antibody should be a useful tool for further studies.
In conclusion, in this study, purified his-pBD2 was used to prepare a polyclonal antibody. The anti-pBD2 antibody was purified, and it showed high sensitivity and specificity. The purified anti-pBD2 antibody reacted with the expressed fusion protein in E. coli and with the native protein in pigs. Furthermore, the distribution of pBD2 protein was identified in different pig tissues. The prepared polyclonal antibody should be a useful tool for the further study of pBD2, including its expression and distribution in various tissues, as well as its function and mechanism of action in the immune system.
